Market condition index · Current read
Rising GLPI indicates accelerating GLP-1 / peptide therapeutics adoption — LLY/NVO dominance, challenger uptake, and spillover into healthcare CPI and consumer spending categories. Falling GLPI indicates reimbursement pressure, competitive shocks, or adoption stalls.
46.8 points below the 50-normal line. This locates the selected condition; it is not a forecast. From one official close publication; stale selected read.
Official closes earn richer presentation. The selected current read is never spliced into certified history.
One point is not a trend and is never connected to the current read.
Only exact governed relationships are navigable. Shared tickers and price moves never create a link.
No Basket, Narrative, or Asset context is inferred from inputs, tickers, price moves, or static “related” lists.
Declared weights explain construction. They do not claim today's contribution or causal impact.
| Input | Source | Formula role | Weight | Cadence |
|---|---|---|---|---|
| LLY | polygon | Price · positive | 25% | Intraday |
| NVO | polygon | Price · positive | 25% | Intraday |
Informational only — not investment advice. MarketSchema is not a registered investment adviser. Condition Percentile reads and indexes are quantitative measurements derived from public market data, not recommendations to buy or sell any security.
| VKTX |
| polygon |
| Price · positive |
| 10% |
| Intraday |
| AMGN | polygon | Price · positive | 8% | Intraday |
| HIMS | polygon | Price · positive | 7.0% | Intraday |
| MCD | polygon | Price · inverse | 5% | Intraday |
| PLNT | polygon | Price · positive | 5% | Intraday |
| DGS10 | fred | Rate · inverse | 8% | Daily |
| PCE | fred | Macro · positive | 7.0% | Monthly |